The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Platelet Dysfunction Due to Drugs

Interventions

DRUG

SGLT2 inhibitor

Sodium-Glucose Like Transporter 2 Inhibitor

Trial Locations (1)

Eric Williams Medical Sciences Complex, Port of Spain

All Listed Sponsors

lead

The University of The West Indies

OTHER

NCT04342819 - The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. | Biotech Hunter | Biotech Hunter